Intra-Articular Lubricin Gene Therapy for Post-Traumatic Arthritis
Abstract
This project focuses on addressing cartilage lubricant failure in post-traumatic osteoarthritis (PTOA) via intra-articular lubricin/proteoglycan 4 (PRG4) gene therapy. Our findings thus far indicate that a single intra-articular injection of adeno-associated virus (AAV) bearing the PRG4 gene in a rabbit ACL transection (ACLT) model resulted intransgene expression until the end-point of the experiment at 8 weeks post-op, and that the injection was significantly chondroprotective, while injections of control virus (AAVGFP) were not. These data indicate that PRG4 gene therapy is a viable option for slowing the progression of PTOA, a finding that warrants progression to a large animal model.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2017
- Accession Number
- AD1042687
Entities
People
- James A. Martin
Organizations
- University of Iowa